Structure via PubChem · Public domain (PubChem)
tropisetron
Sign in to saveAlso known as NAV930
Tropisetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy, although it has been used experimentally as an analgesic in cases of fibromyalgia.
Key facts
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 470618047
- Drug.IUPAC_name
- (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 1methyl-indole-3-carboxylate
- Drug.image
- Tropisetron2DACS.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250
- Drug.image2
- Tropisetron3Dan.gif
- Drug.width2
- 250
- Drug.tradename
- Navoban
- Drug.pregnancy_AU
- B3
- Drug.legal_AU
- S4
- Drug.legal_UK
- POM
- Drug.routes_of_administration
- Oral, intravenous
- Drug.bioavailability
- ~60–80%
- Drug.protein_bound
- 71%
- Drug.metabolism
- Liver (CYP3A4, CYP1A2, CYP2D6)
- Drug.elimination_half life
- 6–8 hours
- Drug.excretion
- Kidney, Feces
via Wikipedia infobox
Chemical data
- Formula
- C17H20N2O2
- Molecular weight
- 284.35 g/mol
- IUPAC name
- [(1S,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate
- SMILES
- CN1[C@H]2CC[C@H]1CC(C2)OC(=O)C3=CNC4=CC=CC=C43
- InChIKey
- ZNRGQMMCGHDTEI-RYUDHWBXSA-N
- XLogP
- 3.8
- Polar surface area
- 45.3 Ų
- H-bond donors
- 1
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Research
1,396 papersvia PubMed
Wikidata facts
- Mass
- 284.15247788
Show 7 more facts
- chemical formula
- C₁₇H₂₀N₂O₂
- canonical SMILES
- CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43
- isomeric SMILES
- CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C3=CNC4=C3C=CC=C4
- NCI Thesaurus ID
- C1131
- World Health Organisation international non-proprietary name
- tropisetron
- Commons category
- Tropisetron
- defined daily dose
- 5
Sources (6)
via Wikidata · CC0
~2 min read
Article
4 sectionsContents
- Pharmacology
- Adverse effects
- Other uses
- References
Tropisetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy, although it has been used experimentally as an analgesic in cases of fibromyalgia.
It was patented in 1982 and approved for medical use in 1992. Tropisetron is a therapeutic alternative on the World Health Organization's List of Essential Medicines. It is sold by Novartis in Europe, Australia, New Zealand, Japan, South Korea and the Philippines as Navoban, but is not available in the US. It is also available from Novell Pharmaceutical Laboratories and sold in several Asian countries as Setrovel.